Arno Therapeutics, Inc.
Arno Therapeutics, Inc. (ARNI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARNI · as of Jun 8, 2026
Key Statistics
Explore Arno Therapeutics, Inc. Data
arni stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
arni competitorsARNI
AMPE
BTTX
BXRXQ
CALA
IVBTStock Performance
Full HistoryAbout Arno Therapeutics, Inc.
Arno Therapeutics, Inc. a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company's product development pipeline includes Onapristone…
what is arno therapeutics, inc. · arni stock overview · arno therapeutics, inc. company profile · who is arno therapeutics, inc. ceo · arni OTC · arno therapeutics, inc. headquarters · arno therapeutics, inc. business segments
About Stock Overview & Key Data
Arno Therapeutics, Inc. (ARNI) is a Healthcare company in the Biotechnology industry, listed on OTC since Jun 11, 2008. As of the latest trading session, ARNI stock price is $0.00, with a market capitalization of $9,870. The stock has returned +100.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2015, Arno Therapeutics, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arno Therapeutics, Inc. (ARNI) stock price is $0.00. The stock is traded on OTC under the ticker symbol ARNI. The 52-week range is $0.00 – $0.00.